So, I was thrilled when, once again, Cort Johnson over at Phoenix Rising posted an excellent, thorough summary of all the latest XMRV news at his blog, Bringing the Heat.
Go on over and take a look - Cort has a real talent for distilling lots of complicated information into an understandable explanation. Bottom line is this:
- The negative replication studies in Europe have had a very bad effect on further funding for research into XMRV's role in CFS.
- There are several possible explanations for the negative results in the European studies, and WPI and the original study's authors still feel confident that XMRV is an important factor in CFS.
- In one negative study (the Dutch one, I think), its authors actually traded samples with WPI and WPI did find XMRV in 3 samples (two from CFS patients and one from a healthy control), but the study's authors went ahead and published their results without even mentioning WPI's contrasting results.